Mesh Placement for Hernia Prevention After Bladder Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines whether using a special mesh called Ultrapro during bladder removal surgery (radical cystectomy) can help prevent hernias, which are tissue bulges that can occur post-surgery. It compares two groups: one undergoes the usual surgery, while the other receives surgery with the mesh. The trial targets individuals having their bladder removed due to cancer and may suit those planning bladder and urine pathway surgery for this reason. The goal is to determine if adding the mesh prevents hernias and to assess any benefits or drawbacks of its use. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants a chance to contribute to a potentially groundbreaking treatment.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that Ultrapro mesh is safe for hernia prevention after bladder surgery?
Research has shown that using Ultrapro mesh during bladder surgery can lower the risk of hernia recurrence. The mesh stabilizes the area post-surgery, potentially reducing the need for additional operations. However, some studies have found that the mesh might cause infections or other complications, possibly leading to further hospital visits or surgeries.
The trial is in a late phase, indicating that a substantial amount of safety information is available. This suggests that most patients tolerate the mesh well, but understanding the possible risks is crucial. Discuss with your doctor to determine if this treatment is suitable for you.12345Why do researchers think this study treatment might be promising?
Researchers are excited about using mesh placement during bladder surgery because it offers a proactive approach to preventing hernias, which can be a common complication after such procedures. Unlike standard surgery that doesn't utilize any additional material to support the abdominal wall, this technique involves placing a mesh at the time of the surgery to reinforce the area and potentially reduce the risk of hernia formation. This innovative step could lead to better long-term outcomes for patients, decreasing the need for additional surgeries and improving recovery times.
What evidence suggests that using Ultrapro mesh during bladder surgery could be effective for hernia prevention?
This trial will compare two approaches: standard bladder surgery and bladder surgery with Ultrapro mesh placement. Studies have shown that using Ultrapro mesh during bladder surgery can help prevent hernias. Research indicates that placing the mesh in a specific way might reduce the chance of hernias forming after surgery. Early results suggest this method can lower the risk of hernias without causing significant extra pain. Although concerns exist about cost and long-term effects, the mesh has proven effective in similar surgeries. Overall, using Ultrapro mesh shows promise for improving surgical outcomes by reducing hernia risk.678910
Who Is on the Research Team?
Bernard Bochner, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
This trial is for patients who are having bladder removal surgery (Radical Cystectomy) due to cancer, without distant spread of the disease and with an expected survival of more than a year. It's not suitable for those undergoing salvage cystectomy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgery
Participants undergo bladder removal surgery, with or without Ultrapro mesh placement
Follow-up
Participants are monitored for safety and effectiveness after surgery to assess the development of parastomal hernia
What Are the Treatments Tested in This Trial?
Interventions
- Radical Cystectomy
- Ultrapro mesh
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor